Publication
Asymmetry in drug permeability through the cornea
| datacite.subject.fos | Ciências Médicas | |
| datacite.subject.sdg | 03:Saúde de Qualidade | |
| dc.contributor.author | Toffoletto, Nadia | |
| dc.contributor.author | Chauhan, Anuj | |
| dc.contributor.author | Alvarez-Lorenzo, Carmen | |
| dc.contributor.author | Saramago, Benilde | |
| dc.contributor.author | Serro, Ana Paula | |
| dc.date.accessioned | 2025-09-15T10:18:18Z | |
| dc.date.available | 2025-09-15T10:18:18Z | |
| dc.date.issued | 2021-05 | |
| dc.description.abstract | The permeability through the cornea determines the ability of a drug or any topically applied compound to cross the tissue and reach the intraocular area. Most of the permeability values found in the literature are obtained considering topical drug formulations, and therefore, refer to the drug permeability inward the eye. However, due to the asymmetry of the corneal tissue, outward drug permeability constitutes a more meaningful parameter when dealing with intraocular drug-delivery systems (i.e., drug-loaded intraocular lenses, intraocular implants or injections). Herein, the permeability coefficients of two commonly administered anti-inflammatory drugs (i.e., bromfenac sodium and dexamethasone sodium) were determined ex vivo using Franz diffusion cells and porcine corneas in both inward and outward configurations. A significantly higher drug accumulation in the cornea was detected in the outward direction, which is consistent with the different characteristics of the corneal layers. Coherently, a higher permeability coefficient was obtained for bromfenac sodium in the outward direction, but no differences were detected for dexamethasone sodium in the two directions. Drug accumulation in the cornea can prolong the therapeutic effect of intraocular drug-release systems. | eng |
| dc.identifier.citation | Toffoletto N, Chauhan A, Alvarez-Lorenzo C, Saramago B, Serro AP. Asymmetry in Drug Permeability through the Cornea. Pharmaceutics. 2021; 13(5):694. https://doi.org/10.3390/pharmaceutics13050694 | |
| dc.identifier.doi | 10.3390/pharmaceutics13050694 | |
| dc.identifier.issn | 1999-4923 | |
| dc.identifier.uri | http://hdl.handle.net/10400.26/58659 | |
| dc.language.iso | eng | |
| dc.peerreviewed | yes | |
| dc.publisher | MDPI | |
| dc.relation.hasversion | https://doi.org/10.3390/pharmaceutics13050694 | |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| dc.subject | cornea | |
| dc.subject | drug permeability | |
| dc.subject | drug accumulation | |
| dc.subject | bromfenac sodium | |
| dc.subject | dexamethasone sodium | |
| dc.title | Asymmetry in drug permeability through the cornea | eng |
| dc.type | contribution to journal | |
| dspace.entity.type | Publication | |
| oaire.citation.issue | 5 | |
| oaire.citation.startPage | 694 | |
| oaire.citation.title | Pharmaceutics | |
| oaire.citation.volume | 13 | |
| oaire.version | http://purl.org/coar/version/c_970fb48d4fbd8a85 |